[Skip to Content]
[Skip to Content Landing]
March 27, 1991

The FDA and Drug Marketing Expenditures

Author Affiliations

Vallejo, Calif

Vallejo, Calif

JAMA. 1991;265(12):1528. doi:10.1001/jama.1991.03460120042027

To the Editor.—  An article in the November 14, 1990, issue of JAMA, "The Federal Regulation of Prescription Drug Advertising and Promotion,"1 was most informative. There was, however, conspicuous failure to address a key question: does the Food and Drug Administration (FDA) consider how much advertising and promotion add to the escalating cost of drugs? An answer to this question is particularly appropriate at this time when there is a public mandate for legislation to control the high cost of medical care.